Qiagen (QGEN) EBIT (2009 - 2025)

Qiagen has reported EBIT for 17 years, with the latest figure at $99.4 million in Q4 2025.

• Quarterly EBIT fell 16.51% year-over-year to $99.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $465.9 million (up 376.76% YoY) and the FY2025 annual result came in at $465.9 million, up 376.76% from the prior year.
• EBIT slipped to $99.4 million in Q4 2025 per QGEN's latest filing, from $129.2 million in the prior quarter.
• Over five years, EBIT peaked at $207.1 million in Q1 2022 and troughed at -$228.4 million in Q2 2024.
• A 5-year average of $105.4 million and a median of $112.1 million in 2024 frame the typical range for EBIT.
• The sharpest annual moves came in 2024 and 2025: EBIT slumped 316.67% in 2024, then surged 153.36% in 2025.
• Over 5 years, EBIT stood at $173.1 million in 2021, then plunged by 39.6% to $104.6 million in 2022, then rose by 5.78% to $110.6 million in 2023, then climbed by 7.67% to $119.1 million in 2024, then fell by 16.51% to $99.4 million in 2025.
• According to Business Quant data, EBIT over the past three periods registered $99.4 million, $129.2 million, and $121.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.